Patents by Inventor Fionnuala Teresa Lundy

Fionnuala Teresa Lundy has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7538087
    Abstract: The present invention relates to a product for preventing periodontal disease wherein the product includes or is based on a Cystatin type peptide. The invention also relates to dentifrice preparations including Cystatin and to medicaments including Cystatin for the treatment or prevention of periodontal disease and to the use of a nucleic acid sequence which encodes a Cystatin type peptide.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: May 26, 2009
    Inventors: Philip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw
  • Patent number: 7396649
    Abstract: The present invention related to the use of Cystatin in predicting onset of migraines. The invention also relates to the use of Cystatin as a vasodilatory agent. The invention also relates to antagonists to Cystatin for use in treating and preventing and treating migraine attacks.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: July 8, 2008
    Assignee: Philip-John Lamey
    Inventors: Philip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw
  • Publication number: 20040185012
    Abstract: The present invention relates to a product for preventing periodontal disease wherein the product includes or is based on a Cystatin type peptide. The invention also relates to dentifrice preparations including Cystatin and to medicaments including Cystatin for the treatment or prevention of periodontal disease and to the use of a nucleic acid sequence which encodes a Cystatin type peptide.
    Type: Application
    Filed: April 8, 2004
    Publication date: September 23, 2004
    Inventors: Philip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw
  • Publication number: 20040092439
    Abstract: The present invention relates to the use of Cystatin in predicting onset of migraines. The invention also relates to the use of Cystatin as a vasodilatory agent. The invention also relates to antagonists to Cystatin for use in preventing and treating migraine attacks.
    Type: Application
    Filed: February 26, 2003
    Publication date: May 13, 2004
    Inventors: Philip-John Lamey, Fionnuala Teresa Lundy, Christopher Shaw